Navigation Links
Soligenix to Present at 8th Annual BIO Investor Forum
Date:10/27/2009

D and an NIH-supported, Phase 2, randomized, double-blind, placebo-controlled trial in the prevention of acute GVHD. Soligenix also expects to begin an NIH-supported Phase 1/2 clinical trial of SGX201 in radiation enteritis in the second half of 2009. Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix's lead biodefense product in development is a recombinant subunit vaccine called RiVax(TM) which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax(TM) has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax(TM) will also be the subject of a recent $9.4 million NIH grant received by the Company supporting development of new heat stable vaccines.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.

This press release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including SGX201, orBec® and LPM(TM), particularly in light of the significant uncertainty inherent in developing vaccines against
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related biology technology :

1. Soligenix Appoints Robert J. Rubin, MD, to its Board of Directors
2. DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol SNGX
3. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2009
4. Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress
5. Sinobiopharma Presents Highlights from Unaudited First Quarter Financial Results for the 3 Month Period Ended August 31, 2009
6. Transdel Pharmaceuticals to Present at Two Investor Conferences
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 2009 BIOCOM INVESTOR CONFERENCE
8. Advanced Life Sciences to Present at 8th Annual BIO Investor Forum
9. Researchers Present a Novel, Automated, Efficient Environmental Disinfection Technology that Significantly Reduces C. difficile, VRE and MRSA Contamination
10. China Pharma Holdings, Inc. to Present at the Roth China Conference on October 14 at 12:00 pm ET
11. 17th International Process Development Conference to Feature Presentations on Safety, Process Development, Crystallization, PAT, Scale-Up and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 MO BIO ... and other challenging microbial nucleic acid purification, announces ... Kit, for extraction of pure protein from all ... coincides with the 20 th anniversary of ... capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper Steve ... Leadership Award. The award will be announced at Bayer’s ... D.C., an event where supporters of pollinator health celebrate ... , The Bayer Bee Care Community Leadership Award ... honey bee colony to benefit their community. Applicants are ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... 19, 2013 Applied Rigaku Technologies, Inc. ... details the measurement of sulfur in ultra-low sulfur diesel ... resolution benchtop EDXRF analyzer . The analysis detailed in ... ISO 13032. This International Standard specifies an energy ... of sulfur content in automotive gasoline. , Regulations around ...
Breaking Biology Technology:MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
... SOUTH SAN FRANCISCO, Calif. , April 29 ... new therapeutics discovered using cellular reprogramming and directed differentiation ... awarded a three-year $1.5 million "Basic Biology ... The grant will be used to fund the study ...
... , VIENNA , April 29, 2010 ... and an obnoxious plant called,Chinese Giant Knotweed, actually improve your brain function? ... ... study in the journal, American Journal of,Clinical Nutrition, which concludes that a ...
... ... and pharmacovigilance training provider, will be speaking today at the 2010 ... President of eLearning and Informatics, will present BioSoteria’s experience with Trivantis ... create online pharmacovigilance training courses for the biopharmaceutical industry. ...
Cached Biology Technology:iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming 2iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming 3Your Brain on Resveratrol 2Your Brain on Resveratrol 3Your Brain on Resveratrol 4Your Brain on Resveratrol 5Drug Safety Firm BioSoteria to Present on eLearning Development Experience 2Drug Safety Firm BioSoteria to Present on eLearning Development Experience 3
(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
(Date:6/18/2013)... are expecting a very large "dead zone" in the ... level in the Chesapeake Bay this year, based on ... University of Michigan, Louisiana State University, and the ... Gulf of Mexico hypoxic "dead" zone will be between ... among the ten largest recorded. That would range from ...
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... eliminate malaria worldwide, new strategies are needed to find ... signs of the disease. The prevalence of asymptomatic or ... percent in populations with malaria and these asymptomatic individuals ... in areas where disease transmission has declined. ...
... latest news and discoveries in medicine, physics, environmental science, ... Annual Meeting of the Biophysical Society (BPS), held Feb. ... Convention Center in San Diego, Calif. With more than ... research scientists in attendance each year, the BPS Annual ...
... of scientists studying the effects of electron-beam irradiation on ... in the February issue of the leading microbiology journal, ... lead investigator. The study quantified the theoretical health-risk ... electron-beam irradiation. "The purpose of this study was ...
Cached Biology News:'Test and Treat' model offers new strategy for eliminating malaria 2Highlights of the Biophysical Society 56th Annual Meeting 2Highlights of the Biophysical Society 56th Annual Meeting 3Highlights of the Biophysical Society 56th Annual Meeting 4Highlights of the Biophysical Society 56th Annual Meeting 5Highlights of the Biophysical Society 56th Annual Meeting 6Highlights of the Biophysical Society 56th Annual Meeting 7Highlights of the Biophysical Society 56th Annual Meeting 8Highlights of the Biophysical Society 56th Annual Meeting 9Highlights of the Biophysical Society 56th Annual Meeting 10Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 2Study shows electron-beam irradiation reduces virus-related health risk in lettuce, spinach 3
Request Info...
Tracker Datamatrix RS-1* reads 96 2D Bar-coded tubes within 20 seconds....
Hybridization cassette for one slide...
Complete cell culture media with cytokines...
Biology Products: